Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 BMC Cancer
26 Br J Dermatol
2 Cancer
1 Cancer Res
4 Clin Dermatol
6 Clin Exp Dermatol
2 Int J Cancer
3 Int J Dermatol
1 Intern Med
1 J Cutan Pathol
6 J Dermatol
3 J Invest Dermatol
1 Mycoses
7 PLoS One

    BMC Cancer

  1. GILL J, Yendamuri K, Chatterjee U, Yao S, et al
    Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
    BMC Cancer. 2024;24:461.
    >> Share

    Br J Dermatol

    Shedding light on the smoke: Unraveling the impact of smoking cessation on psoriasis development.
    Br J Dermatol. 2024 Apr 15:ljae163. doi: 10.1093.
    >> Share

  3. CHAIYABUTR C, Dawe R, Lesar A, Ibbotson SH, et al
    A retrospective comparison of early- and late-onset chronic actinic dermatitis: characteristics and management.
    Br J Dermatol. 2024 Apr 16:ljae101. doi: 10.1093.
    >> Share

  4. The 2024 British Skin Foundation Research Awards are now available.
    Br J Dermatol. 2024;190:778.
    >> Share

  5. HUANG D, Zhong X, Jiang Y, Kong L, et al
    Insulin Resistance Impairs Biological Agents Response in Moderate-to-Severe Plaque Psoriasis: Insights from a Prospective Cohort Study in China.
    Br J Dermatol. 2024 Apr 18:ljae147. doi: 10.1093.
    >> Share

  6. LEEOLOU MC, Sarin KY, Fiorentino DF
    Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.
    Br J Dermatol. 2024 Apr 18:ljae168. doi: 10.1093.
    >> Share

  7. VAN BEEK N, Eming R, Reuss A, Zillikens D, et al
    Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
    Br J Dermatol. 2024;190:657-667.
    >> Share

  8. RIVERA S, Dehner K, Flood A, Dykstra C, et al
    Adverse healthcare experiences are correlated with increased time to diagnosis in women with vulvar inflammatory dermatoses: a retrospective cohort survey.
    Br J Dermatol. 2024;190:761-762.
    >> Share

  9. HASHIMOTO T, Yamagami J
    Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapy.
    Br J Dermatol. 2024;190:609.
    >> Share

  10. SAAD R, Duipmans J, Yerlett N, Plevey K, et al
    Neonatal Epidermolysis Bullosa: a clinical practice guideline.
    Br J Dermatol. 2024 Jan 4:ljae006. doi: 10.1093.
    >> Share

  11. FAKIH A, Tannous R, Lajnef M, Seneschal J, et al
    Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score.
    Br J Dermatol. 2024;190:712-717.
    >> Share

  12. RING HC, Thorsen J, Kirby B, Ingram JR, et al
    Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
    Br J Dermatol. 2024;190:769-771.
    >> Share

  13. MOSS C
    Caring for babies born with epidermolysis bullosa.
    Br J Dermatol. 2024;190:608.
    >> Share

  14. KYUNG S, Woo S, Kim M, Lee H, et al
    Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database.
    Br J Dermatol. 2024;190:764-767.
    >> Share

  15. The association between vitamin D levels and psoriasis in people aged 40-79 years.
    Br J Dermatol. 2024;190:e54.
    >> Share

  16. Effectiveness and safety of immunoadsorption in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Br J Dermatol. 2024;190:e53.
    >> Share

  17. Predictors of response to treatment with biologics in people with moderate-to-severe psoriasis.
    Br J Dermatol. 2024;190:e55.
    >> Share

  18. A novel strategy for the treatment of melanoma.
    Br J Dermatol. 2024;190:e51.
    >> Share

  19. Practical guide for epidermolysis bullosa management in the first 4 weeks of life.
    Br J Dermatol. 2024;190:e52.
    >> Share

  20. The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasis.
    Br J Dermatol. 2024;190:e56.
    >> Share

  21. Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) tool.
    Br J Dermatol. 2024;190:e57.
    >> Share

  22. Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment.
    Br J Dermatol. 2024;190:e58.
    >> Share

  23. UK trends in work-related contact dermatitis caused by nickel, chromium and cobalt.
    Br J Dermatol. 2024;190:e59.
    >> Share

  24. 'Gene creams' for genetic diseases?
    Br J Dermatol. 2024;190:e50.
    >> Share

    A pledge for a better care and consideration of patients with vitiligo.
    Br J Dermatol. 2024;190:614-615.
    >> Share

  26. SAMPOGNA F, Piaserico S
    Deucravacitinib: is there still a place or a need for a new oral agent?
    Br J Dermatol. 2024;190:610-611.
    >> Share

  27. HASAN SB, Bates J, Cannings-John R, Collier F, et al
    Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study.
    Br J Dermatol. 2024;190:775-777.
    >> Share


  28. BHATT R, van den Hout A, Antoniou AC, Shah M, et al
    Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.
    Cancer. 2024 Jan 4. doi: 10.1002/cncr.35183.
    >> Share

  29. AKKOC MUSTAFAYEV FN, Shukla MA, Lanier A, Milton DR, et al
    Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations.
    Cancer. 2023 Dec 15. doi: 10.1002/cncr.35159.
    >> Share

    Cancer Res

  30. YAN L, Wu M, Wang T, Yuan H, et al
    Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming that Drives Immune Evasion.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2390.
    >> Share

    Clin Dermatol

  31. PARENTE JBM, Silva GS, Gotschall JW, Ferreira AL, et al
    Cosmetic Skin Lightening: Contextualizing Biomedical and Ethical Issues.
    Clin Dermatol. 2024 Apr 12:S0738-081X(24)00058.
    >> Share

  32. BOBOTSIS R, Brathwaite S, Eshtiaghi P, Rodriguez-Bolanos F, et al
    HIV: Inflammatory dermatoses.
    Clin Dermatol. 2024;42:169-179.
    >> Share

  33. CHANDLER DJ, Walker SL
    HIV and skin infections.
    Clin Dermatol. 2024;42:155-168.
    >> Share

  34. HOENIG LJ, Brenner S, Wolf R, Ingber A, et al
    Eponyms and clinical entities from the land of Israel.
    Clin Dermatol. 2024;42:201-205.
    >> Share

    Clin Exp Dermatol

  35. FANG S, Zhang L, Wang P, Shi L, et al
    Real-world data of 5-aminolevulinic acid-mediated photodynamic therapy for Bowen's disease: A 10-year retrospective study in the skin of color patients (2011-2021).
    Clin Exp Dermatol. 2024 Apr 20:llae139. doi: 10.1093.
    >> Share

  36. TUTIC-SORRENTINO L, Cazzaniga S, Feldmeyer L, Benzaquen M, et al
    PET-CT vs brain MRI for the detection of cerebral metastases of melanoma, a 5-year retrospective study.
    Clin Exp Dermatol. 2024 Apr 16:llae129. doi: 10.1093.
    >> Share

  37. NINKOV T, Chan J, Von Nida J
    A Case of Terbinafine-Induced Subacute Cutaneous Lupus Erythematosus rapidly resolving with Upadacitinib.
    Clin Exp Dermatol. 2024 Apr 15:llae138. doi: 10.1093.
    >> Share

  38. HUSEIN-ELAHMED H, Husein-ElAhmed S
    Assessing the 5-year persistence in positive clinical response with innovative psoriasis treatments: a network meta-analysis of pasi score.
    Clin Exp Dermatol. 2024 Apr 15:llae131. doi: 10.1093.
    >> Share

  39. SHAW VR, Damsky W, Homer RJ, Cohen JM, et al
    Characterizing interstitial lung disease among patients with psoriasis: A cross-sectional analysis in the NIH All of Us Research Program.
    Clin Exp Dermatol. 2024 Apr 15:llae132. doi: 10.1093.
    >> Share

  40. KRONBORG L, Hansen EO, Bertelsen T, Rittig AH, et al
    ERAP1 and ERAP2 Gene Variants as Potential Clinical Biomarkers of Anti-IL-17A Response in Psoriasis Vulgaris.
    Clin Exp Dermatol. 2024 Apr 15:llae128. doi: 10.1093.
    >> Share

    Int J Cancer

  41. FROHLICH LM, Villar-Miyar A, Heintze T, Sauer B, et al
    PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma.
    Int J Cancer. 2024 Apr 15. doi: 10.1002/ijc.34947.
    >> Share

  42. KAMEI M, Matsuo K, Yoshida Y, Shimada K, et al
    Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells.
    Int J Cancer. 2024;154:2176-2188.
    >> Share

    Int J Dermatol

  43. SHEHATA WA, Hammam MA, Elbakly AR, Elkady N, et al
    Reappraisal of psoriasis pathogenesis: the role of TEAD4 expression in keratinocytes.
    Int J Dermatol. 2024 Apr 18. doi: 10.1111/ijd.17187.
    >> Share

  44. HU K, Liu Y, Liu Y, Jian L, et al
    Rapid and sustained resolution in generalized pustular psoriasis with IL-17A inhibitors required high adherence: a 96-week analysis in a real-life setting.
    Int J Dermatol. 2024 Apr 17. doi: 10.1111/ijd.17163.
    >> Share

  45. LIU F, Zhang J
    Abrocitinib: a useful treatment option for CARD14-mutation-associated atopic dermatitis.
    Int J Dermatol. 2024 Apr 12. doi: 10.1111/ijd.17183.
    >> Share

    Intern Med

  46. IWASHIGE Y, Yamamoto S, Ohue K, Sugimoto H, et al
    A Rare Case of Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Leading to Hemodialysis and Multiple Infections: A Case Report and Literature Review.
    Intern Med. 2024;63:1131-1138.
    >> Share

    J Cutan Pathol

  47. ZENGIN S, Guthrie J, Zoumberos N, Hamza M, et al
    Sebaceous gland atrophy due to seborrheic dermatitis in a patient with alopecia: A potential pitfall.
    J Cutan Pathol. 2024 Apr 13. doi: 10.1111/cup.14623.
    >> Share

    J Dermatol

  48. TAKAHASHI T, Takahashi T, Ikawa T, Terui H, et al
    Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
    J Dermatol. 2024 Apr 15. doi: 10.1111/1346-8138.17233.
    >> Share

  49. ZHANG L, Jin L, Zhao Y, Cai H, et al
    A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17236.
    >> Share

  50. TAKAHASHI-WATANABE M, Fujimura T, Amagai R, Ohuchi K, et al
    Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17221.
    >> Share

  51. KIM DS, Kim JC, Baek DJ, Kang HY, et al
    Successful repigmentation of hypopigmented scars with micropunch grafting with a skin-seeding technique.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17216.
    >> Share

  52. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    >> Share

  53. MINAGAWA A, Koga H, Matsunaga K, Hamada A, et al
    Difference in computer-assistance effects on human doctor accuracy in diagnosing acral and non-acral pigmented skin tumors.
    J Dermatol. 2024 Apr 18. doi: 10.1111/1346-8138.17240.
    >> Share

    J Invest Dermatol

  54. CHEN M, Li J, Ding Y, Zhang C, et al
    Skin Aging Research Enters a New Era in China.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00266.
    >> Share

  55. KOHL LM, Sumpter TL
    The ART(N) of Keratinocytes Leading Neurons into the Skin.
    J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00191.
    >> Share

  56. SAKAGUCHI S, Tsutsumi M, Akita S, Konyo M, et al
    Human Merkel cells as the initiator of mechanotransduction in skin: Linking the animal model to humans.
    J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00278.
    >> Share


  57. GUPTA AK, Wang T, Polla Ravi S, Mann A, et al
    Global prevalence of onychomycosis in general and special populations: An updated perspective.
    Mycoses. 2024;67:e13725.
    >> Share

    PLoS One

  58. GAO S, Tang L, Ma J, Wang K, et al
    Evaluation of the mechanism of Gong Ying San activity on dairy cows mastitis by network pharmacology and metabolomics analysis.
    PLoS One. 2024;19:e0299234.
    >> Share

  59. BUJA A, Rugge M, Cozzolino C, Dossi F, et al
    Could the mitotic count improve personalized prognosis in melanoma patients?
    PLoS One. 2024;19:e0302309.
    >> Share

  60. CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
    Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    PLoS One. 2024;19:e0290632.
    >> Share

  61. ALLANA A, Shamsi U, Rashid Y, Khan FR, et al
    Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study.
    PLoS One. 2024;19:e0295456.
    >> Share

  62. ZEIN H, Chantaf S, Fournier R, Nait-Ali A, et al
    Generative adversarial networks for anonymous acneic face dataset generation.
    PLoS One. 2024;19:e0297958.
    >> Share

  63. MATTHIES L, Amir-Kabirian H, Gebrekidan MT, Braeuer AS, et al
    Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
    PLoS One. 2024;19:e0302017.
    >> Share

    An improved breast cancer classification with hybrid chaotic sand cat and Remora Optimization feature selection algorithm.
    PLoS One. 2024;19:e0300622.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016